| Dana Taddei, PHARMD | |
|
1220 Sonoma Ave, Santa Rosa, CA 95405 | |
| (707) 546-9090 | |
| (707) 526-5912 |
| Full Name | Dana Taddei |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1220 Sonoma Ave, Santa Rosa, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205185121 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 45474 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dana Taddei, PHARMD 1404 Snowy Egret Drive, Santa Rosa, CA 95409 Ph: (707) 246-7381 | Dana Taddei, PHARMD 1220 Sonoma Ave, Santa Rosa, CA 95405 Ph: (707) 546-9090 |
News Archive
Women 40 years and younger with early-stage breast cancer who receive an additional high dose of radiation (boost dose) after undergoing breast-conserving surgery (lumpectomy) and standard radiation treatment are almost twice as likely to be free of cancer 10 years after treatment compared to those who don't receive the boost dose, according to a large European study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Finnish scientists have reported a breakthrough in the attempts to understand the development of type 1 diabetes.
XDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value non-invasive diagnostic tests to monitor immune-mediated conditions, today announced that Highmark Inc., an independent licensee of the Blue Cross Blue Shield Association, is now covering AlloMap for its beneficiaries.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that between December 8, 2010 and February 9, 2011 it entered into agreements with certain accredited investors, pursuant to which the Company sold to the purchasers in the aggregate approximately $7.8 million of the Company's Series D convertible preferred stock, which is convertible into shares of common stock at a conversion price of $0.50 per share.
A Kansas State University team recently received a nearly $1.3 million grant from the National Science Foundation's Major Research Institute for a biomedical instrument that is anticipated to help with breakthroughs in animal and human health as well as cancer treatment.
› Verified 8 days ago
Mr. Gregory Lee Kappes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1055 W College Ave, Santa Rosa, CA 95401 Phone: 707-484-7104 | |
Christopher Nhiawa Vang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3093 Marlow Rd, Santa Rosa, CA 95403 Phone: 707-569-8504 | |
Jie Giok Rahardja, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 707-393-4652 | |
Conor William Bowman, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 818-522-1238 | |
Dr. Justin Colucci, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 707-393-4119 Fax: 866-296-6825 | |
Dr. Michael Wollman Sanders I, PHARM.D., C.G.P. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 128 Alderbrook Dr, Santa Rosa, CA 95405 Phone: 707-545-0742 Fax: 707-545-0742 | |
Mr. Mark Allen Guttormsen, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1055 W College Ave, Santa Rosa, CA 95401 Phone: 707-575-1313 Fax: 707-575-0104 |